Skip to content

Biogen BIIB Gross Profit

Gross Profit at other companies

Eli Lilly logo
Eli LillyLLY
$16.22B+54.4%
Rogers Corporation logo
Rogers CorporationROG
$64.6M+13.3%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$243.27M+8.6%
Organon logo
OrganonOGN
$783M-6.9%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$134.92M+9.2%
TG Therapeutics logo
TG TherapeuticsTGTX

Other financials

Income statement

See full
Revenue$2.5B+1.9%
Operating income$610.7M
Net income$319.5M+32.8%
EPS (diluted)$2.15+31.1%

Balance sheet

See full
Cash & equivalents$3.4B+30.2%
Total debt$6.6B+34.7%
Total equity$18.7B+9.9%
Total assets$29.5B+5.2%

Cash flow

See full
Operating cash flow$645.5M+149%
CapEx$51.2M+38.0%
Free cash flow$594.3M+167%

Valuation

See full
Market cap$31.9B+71.6%
Enterprise value$35.08B+56.4%
P/E22.5×+10.3×
P/S3.2×+1.4×

Profitability

See full
Gross margin75.5%-0.1pp
Operating margin22.9%
Net margin14.3%-0.8pp
FCF margin24.4%-0.4pp

Returns & leverage

See full
Return on equity8%-1.2pp
Debt / equity0.4×+0.1×
Current ratio3.1×+1.6×

Where this comes from

Calculated from Biogen’s reported figures.

The official record: Biogen’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biogen's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biogen's gross profit?
Biogen (BIIB) reported gross profit of $1.82B in Q1 2026.
How has Biogen's gross profit changed year-over-year?
Biogen's gross profit increased by 0.8% year-over-year, from $1.8B to $1.82B.
What is the long-term trend for Biogen's gross profit?
Over 4 years (2021 to 2025), Biogen's gross profit has grown at a -4.2% compound annual growth rate (CAGR), from $8.87B to $7.49B.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.